The Serum Institute of India has expanded Covovax’s paediatric trial in seven to 11 years age bracket across 10 sites in India, including Pune, after ensuring vaccine safety in adolescents. The Covishield maker aims to scale the paediatric trial further by including kids in the two to six years age-bracket in the trial’s immediate next phase.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3muzWNB
0 Comments:
Post a Comment